Waiving patent rights on COVID-19 vaccines and drugs is still crucial to ensure access globally, but the waiver on the table at the June World Trade Organization meeting doesn’t do the job.
Academic rigor, journalistic flair
Articles on Pfizer
Displaying 1 - 20 of 104 articles
Boosters and vaccinating children mean we’re relying on two pharmaceutical companies to supply Australia’s COVID vaccines. That needs to change.
The COVID-19 pandemic has brought immunology terms that are typically relegated to textbooks into our everyday vernacular. These stories helped us make sense of the ever-evolving science.
Fewer people reported needing to miss work after their booster, compared to their second dose.
Both companies say their drugs will work against the Omicron variant, though this is based on preliminary, lab-based research.
We’re reliant on overseas supply - and the many moving parts of delivery. Each of those parts require staff on the ground – and many workers in this system are likely being affected by Omicron.
Even with a variant like Omicron that may be more transmissible than earlier variants, vaccines remain the most effective tool for protection against COVID-19 and for ending the pandemic.
The Pfizer COVID-19 vaccine will be available for children aged 5-11 from January 10, after it cleared the final regulatory step. Here’s what you need to know.
The world needs to learn to live with the virus. And governments must follow the science and don’t distort it for political expediency.
Merck and Pfizer both have oral antiviral pills under review by the FDA. Such treatments could help turn the tide of the pandemic.
Properly engaged and monitored, Nigeria’s private sector can do more in COVID vaccination exercise.
Paxlovid is one potential COVID drug for use at home. The idea is these can potentially be prescribed at the first sign of infection to prevent serious illness and death.
The focus of the government seems to be about how many people can get vaccinated rather than ensuring the greatest protection against severe disease and deaths.
CC BY-NC-ND23.3 MB (download)
South Africa has a vaccine supply, but the challenge is using the doses effectively before they expire.
Pediatric clinical trials for the COVID-19 Pfizer vaccine for children ages 5 to 11 have shown that the Pfizer shot is safe and effective.
Protection from infection wanes over time. So boosters will offer extra protection and hopefully reduce the spread of the virus even further.
As boosters are authorized for all three COVID-19 shots available in the US, the ability to swap out vaccine types looks to be a boon to the immune system.
Modelling suggested Sydney would open up when NSW had around 1,900 new daily cases. Last Monday, it eased restrictions with just 496 new cases.
In light of mounting research showing the serious risks of contracting COVID-19 during pregnancy, the CDC is re-upping its urgency that pregnant women get their shots.
There are very few situations where someone can’t have a COVID vaccine for medical reasons.
Top contributors
-
Associate Professor and ARC Future Fellow, The University of Western Australia
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Professor of Medicine, University of Virginia
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professorial Fellow, University of Canberra
-
Project Coordinator & Staff Scientist, Vanderbilt University Medical Center, Vanderbilt University
-
Instructor of Human Immunology, Emory University
-
Associate Professor of the Sydney Pharmacy School, University of Sydney
-
Professor of Global Biosecurity, NHMRC Principal Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professor of Business, University of Michigan
-
Professor Emeritus of Health Policy and Management, York University, Canada
-
Associate Professor of Biology, Rochester Institute of Technology
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Pharmacist and PhD Candidate, University of Sydney
-
Assistant Professor, School of Professional Communication, Toronto Metropolitan University
